Biosino Bio-tec (08247) announced that He Xin, who holds approximately 7.83% of the company's issued share capital, has been nominated as an independent non-executive director candidate by the shareholder Jingning Guoke Kangyi Enterprise Management Center (Limited Partnership) (Jingning Guoke) and will be submitted to the company for deliberation at the annual general meeting of shareholders to be held on June 28, 2024. If appointed, the term of office will last from the date of approval by the annual general meeting of shareholders until the expiration of the current term of the board of directors.
According to the recommendation of Jingning Guoke and the review of the supervisory board, Biosino Bio-tec (08247) announced that He Xin, who holds approximately 7.83% of the company's issued share capital, has been nominated as a candidate for independent non-executive director and will be submitted to the company for deliberation at the annual general meeting of shareholders to be held on June 28, 2024, if appointed. The term of office will last until the expiration of the current term of the board of directors.
The board of directors hereby announces that, based on the recommendation of Jingning Guoke and the review of the supervisory board, it is recommended to appoint Fan Hua as the shareholder representative supervisor and chairman of the supervisory board.